Overview

Amikacin Penetration Into the Cerebrospinal Fluid

Status:
Withdrawn
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The limited available data precludes establishing an antibiotic regimen in patients suffering from bacterial meningitis after head trauma, or spontaneous bleeding Understanding the disposition of Amikacin administered intrathecally will enable to propose rational treatment of these patients.
Phase:
Phase 4
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Amikacin